Trial Profile
Incontinence & Intimate Partners: Assessing the Contribution of Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2019
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Sexual function disorders; Urinary incontinence
- Focus Therapeutic Use
- Acronyms IIMPACT
- 28 Feb 2017 Status changed from active, no longer recruiting to completed.
- 07 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.